University Of California San Diego
Many drug therapy options exist for NAFLD
Lipid-lowering therapies, diabetes drugs and liver-related therapies are among the medication options for patients with nonalcoholic fatty liver disease, according to a presentation at the National Lipid Association Scientific Sessions.
Active surveillance not linked to higher mortality for Black men with prostate cancer
Black men with low-risk prostate cancer had a significantly higher 10-year cumulative incidence of disease progression and definitive treatment than white men, according to results of a retrospective cohort study published in JAMA.
Young and female patients with cancer may not respond as well to immunotherapy
The immune cells of young and female individuals typically are very potent due to genetic and hormonal factors.
Nephrology News & Issues names new associate editors
Healio has named Graham Abra, MD, and Anna Burgner, MD, MEHP, associate editors for Nephrology News & Issues and Healio Nephrology. The positions are new additions to the Nephrology News & Issues Editorial Advisory Board.
TRACK study to assess precision medicine in rare cancers
Precision medicine in cancer treatment has gained momentum due to advances in genomics and the mechanisms of targeted therapies.
Combination therapy, personalized medicine on the horizon in psoriatic arthritis
There is much to look forward to in the management of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.
IV phage therapy shows promise against resistant infections
IV bacteriophage therapy was safe and showed promise against an assortment of infections, according to findings from a case series published in Open Forum Infectious Diseases.
Blood test detects common cancer types 4 years before current screening methods
A novel blood-based assay demonstrated the ability to detect five cancer types up to 4 years earlier than current screening methods, according to study results published in Nature Communications.
New guidance on long-term noninvasive ventilation in chronic stable hypercapnic COPD
A new clinical practice guideline addresses limited evidence and provides new recommendations for management of noninvasive ventilation in patients with COPD and chronic hypercapnia.
Selpercatinib effective, safe in RET-altered thyroid cancer, NSCLC
Selpercatinib appeared to be effective and safe for patients with RET-altered medullary thyroid cancer and RET fusion-positive non-small cell lung cancer, according to results of two studies published in The New England Journal of Medicine.